Navigation Links
Gene Studies of Male-Female Differences Often Flawed
Date:8/21/2007

Too often, statistics are weak or unsubstantiated, review finds

TUESDAY, Aug. 21 (HealthDay News) -- Claims of male-female differences in how genes affect disease often lack proper documentation or validation, experts report in the Aug. 22/29 issue of the Journal of the American Medical Association.

A team of researchers in Greece analyzed 77 studies that contained 432 gender-difference claims.

They found that 286 (66.2 percent) of these claims were decided in advance of the study, and 68 (15.7 percent) were drawn from post-study analyses. The analysis plan was unclear in 78 (18.1 percent) of the studies.

The review also found that appropriate documentation of gene-sex interaction was recorded in just 55 claims (12.7 percent), while there was insufficient documentation for 303 claims and invalid documentation for 74 claims.

Dr. Nikolaos A. Patsopoulos of the University of Ioannina School of Medicine and colleagues concluded that "the majority of these claims were insufficiently documented or spurious, and reporting of statistical interaction tests was rare."

"We hope that our empirical evaluation will help sensitize clinicians, geneticists, epidemiologists, and statisticians who are pursuing subgroup analyses by sex or other subgroups on genetic associations," the researchers said.

In many cases, the proof of any real gender-based gene differences was weak. For example, data for re-analysis of gender-difference claims were available for 188 comparisons, the research team said. Of those, 83 (44.1 percent) were nominally statistically significant, and more than half of those (44) failed to reach nominal statistical significance of a certain level, the review authors said.

Of 60 claims with seemingly "the best internal validity," only one was consistently replicated in at least two other studies.

Studies of gene-sex interactions shouldn't be abandoned but should be conducted using more rigorous standards and documentation, the Greek team said. In addition, the results of such studies should be replicated by several other studies before the findings are accepted as valid, they wrote.

More information

The U.S. Food and Drug Administration has more about gender and disease.



-- Robert Preidt



SOURCE: JAMA news release, Aug. 21, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Studies On Hearing Loss Discovers New Causes
2. Broccoli Found to Block Cancer Progression In Both Animal and Human Studies
3. Studies Report Mammograms Unsafe
4. Six Indians Win Australian Studies Fellowships
5. Cure For Autism Could Be Established Through Hamster Studies
6. Despite More Studies Researchers Are Still Confound With ADHD
7. Studies Show Brain becomes Less Specialized With Age
8. ISB To Establish Research Chair On Real Estate And Urban Studies
9. Studies Show Combination Drugs As A Poor Substitute For Anti-Coagulants In Stroke
10. Further Studies Needed To Completely Understand About Ventricular Fibrillation
11. Circumcision Studies to Continue Says Health Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the ... ended December 31, 2015 on Monday, February 29, 2016 after the market closes. , ... the release at 4:30 PM ET. Investors interested in participating by phone are invited ...
(Date:2/10/2016)... AZ (PRWEB) , ... February 10, 2016 , ... For ... in new book , Pioneering book "Better with Age: The Ultimate Guide to Brain ... neuroplasticity can improve memory. The book’s publication date is March 16, 2016. ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX ... accessories. These PEEK-lined stainless steel (PLS) columns combine the strength of traditional stainless ... the integrity of biological samples while operating at ultra-high pressures of 20,000 psi. ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... The recreational ... cannabis enthusiasts in the state still face a lot of restrictions as to where ... is intended for private, personal use” and that cannabis “may not be consumed openly ...
(Date:2/10/2016)... ... 2016 , ... Ross A. Clevens, MD, FACS , ... a new addition to their growing practice. Beginning this month, Teresa Imperiale-Westerfield, a ... performing cosmetic procedures including injectables, fillers and laser treatments. A master ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Mass. , Feb. 9, 2016  Insulet Corporation (NASDAQ: ... tubeless insulin pump technology with its OmniPod ... David A. Lemoine has been appointed to Insulet,s Board ... of nine directors, eight of whom are independent. ... 40 years of audit and finance experience and a deep ...
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... Bermuda, Feb. 9, 2016  Axovant Sciences Ltd. ... on the treatment of dementia, today announced further ... cognitive, behavioral and functional aspects of Lewy body ... in the U.S. Two out of the three ... expected to start later this quarter. In addition, ...
Breaking Medicine Technology: